Australia markets open in 6 hours 12 minutes

Tonix Pharmaceuticals Holding Corp (TPM.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.3590-0.0010 (-0.28%)
At close: 08:04AM CET
Full screen
Previous close0.3600
Open0.3590
Bid0.3710 x N/A
Ask0.3860 x N/A
Day's range0.3590 - 0.3590
52-week range0.3590 - 16.1920
Volume0
Avg. volume699
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date07 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Tonix Pharmaceuticals to Participate in the A.G.P. Biotech Conference

    CHATHAM, N.J., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that management will participate virtually in the A.G.P. Biotech Conference and host investor meetings. The conference is being held Wednesday, November 30, 2022 – Thursday, December 1, 2022. Investors interested in arranging a meeting with the Company’s management during the conference should contact the conference coordinator or Ian Fr

  • GlobeNewswire

    Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine and Immunotherapy Congress

    CHATHAM, N.J., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will deliver an oral presentation at the World Vaccine and Immunotherapy Congress 2022, which will be held in San Diego, Calif., November 28 - December 1, 2022. A copy of the Company’s presentation will be available under the Scientific Presentations tab of the T

  • GlobeNewswire

    Tonix Pharmaceuticals Announces Oral Presentation at the World Antiviral Congress

    CHATHAM, N.J., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will deliver an oral presentation at the World Antiviral Congress 2022, which will be held in San Diego, Calif., November 28 - December 1, 2022. A copy of the presentation will be available under the Scientific Presentations tab of the Tonix website at www.tonixp